ABSI vs MESO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ABSI · Absci Corp$10.17 ▲ 8.31%
MESO · Mesoblast$14.27 ▲ 1.21%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ABSI +206.3%
- MESO -6.2%
Head to head
| Metric | ABSI | MESO |
|---|---|---|
| Price | $10.17 | $14.27 |
| Change today | ▲ 8.31% | ▲ 1.21% |
| Market cap | $1.75B | $1.86B |
| Return, 3 months | +12.9% | -14.4% |
| Return, year to date | +191.4% | -20.9% |
| Return, 1 year | +204.9% | -2.3% |
| P/E (TTM) | – | – |
| P/B | 7.1 | 3.3 |
| P/E percentile vs own 5y | 1st | 1st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -46.4% | -3.8% |
| Net profit growth (YoY) | -8.6% | -2.2% |
| Gross margin | – | 86.1% |
| Operating margin | -8,411.3% | -42.6% |
| Net margin | -7,756.4% | -47.8% |
| Return on equity | -57.7% | -9.9% |
| Analyst target vs. price | +43.2% | +159.3% |
| Analyst buy share | 90% | 100% |
| RSI (14) | 51 | 51 |
| 30-day volatility | 118.8% | 71.5% |
| Max drawdown, 1 year | -48.9% | -43.0% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MESO is the largest of the group by market value.
- ABSI has returned the most over the past year.
- MESO is growing revenue fastest.
- MESO keeps the most profit per dollar of sales.
- MESO has been the calmest stock over the last 30 days.